Passage BIO, Inc. (PASG) Insider Trading -- Recent Executive & Director Transactions

6 insiders reported 36 Form 4 transactions for Passage BIO, Inc. (PASG) over the past 18 months (most recent 2026-06-29). Recent activity: Nichols Weston (10% Owner) Buy 50,055 shares, Lynx1 Capital Management LP (10% Owner) Buy 50,055 shares, Borthwick Kathleen (CFO) Buy 5,000 shares, Borthwick Kathleen (CFO) Sell 2,062 shares, Chou William (PRESIDENT AND CEO) Buy 10,000 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2026-06-29Nichols Weston10% OwnerBuy50,055$206,101
2026-06-29Lynx1 Capital Management LP10% OwnerBuy50,055$206,101
2026-01-12Borthwick KathleenCFOBuy5,000$0
2026-01-12Borthwick KathleenCFOSell2,062$38,023
2026-01-12Chou WilliamPRESIDENT AND CEOBuy10,000$0
2026-01-12Chou WilliamPRESIDENT AND CEOSell4,076$75,161
2025-09-15Nichols WestonInsiderBuy325$2,262
2025-09-15Lynx1 Capital Management LPInsiderBuy325$2,262
2025-09-15Nichols WestonInsiderBuy19,783$138,283
2025-09-15Lynx1 Capital Management LPInsiderBuy19,783$138,283
2025-09-15Nichols WestonInsiderBuy11,900$83,181
2025-09-15Lynx1 Capital Management LPInsiderBuy11,900$83,181
2025-07-24Nichols WestonInsiderBuy13,123$71,389
2025-07-24Lynx1 Capital Management LPInsiderBuy13,123$71,389
2025-07-24Nichols WestonInsiderBuy49,302$282,993
2025-07-24Lynx1 Capital Management LPInsiderBuy49,302$282,993
2025-07-24Nichols WestonInsiderBuy66,423$379,275
2025-07-24Lynx1 Capital Management LPInsiderBuy66,423$379,275
2025-06-26ORBIMED ADVISORS LLCInsiderSell231,600$81,060
2025-06-26OrbiMed Capital GP VII LLCInsiderSell231,600$81,060
2025-06-26ORBIMED ADVISORS LLCInsiderSell138,800$45,804
2025-06-26OrbiMed Capital GP VII LLCInsiderSell138,800$45,804
2025-06-26ORBIMED ADVISORS LLCInsiderSell213,257$70,375
2025-06-26OrbiMed Capital GP VII LLCInsiderSell213,257$70,375
2025-04-24ORBIMED ADVISORS LLCInsiderSell78,049$26,537

Source: SEC Form 4 filings · as of 2026-06-29